Die Schweiz im internationalen Energie-Benchmark : Selektion der europäischen Vergleichsländer

Die Schweizer Energiestrategie 2050 sieht eine grundlegende Veränderung in der Stromerzeugung (und im Stromverbrauch) sowie eine starke Reduktion des Gesamtenergieverbrauchs vor. Davon kann der Schweizer Energiemarkt gesellschaftlich und unternehmerisch profitieren. Die Anforderungen, die für die Erreichung der Ziele der nationalen Energiestrategie 2050 erfüllt werden müssen, stellen den Energiemarkt – insbesondere den Strommarkt – jedoch auch vor neue Herausforderungen. Diese befinden sich nicht nur auf der politischen und gesetzlichen Ebene, sondern unter anderem auch in den Bereichen Energieverteilung und -speicherung, Subventionen sowie neue Technologien. Ziel dieser Arbeit ist, die Schweiz mit drei führenden europäischen Ländern im Bereich erneuerbare Energien zu vergleichen, um die Bewältigung dieser Herausforderungen unterstützen und allfällige Empfehlungen für die Politik formulieren zu können. Diese Arbeit widmet sich somit der Fragestellung: Warum sind diese Länder in spezifischen, nachhaltigen Energiebereichen erfolgreich und was kann die Schweiz von ihnen lernen? Im vorliegenden Artikel werden zuerst die verschiedenen Herausforderungen für die Schweiz erklärt. Anschliessend werden die Auswahlkriterien der zu vergleichenden Länder erläutert sowie die drei ausgewählten Länder Dänemark, Österreich und Schweden kurz vorgestellt. Der Benchmark der Schweiz mit diesen drei Ländern sowie dessen Resultate werden Teil des zweiten Artikels im Jahre 2017 sein

Activation of p53-regulated pro-apoptotic signaling pathways in PrP-mediated myopathy

<p>Abstract</p> <p>Background</p> <p>We have reported that doxycycline-induced over-expression of wild type prion protein (PrP) in skeletal muscles of Tg(HQK) mice is sufficient to cause a primary myopathy with no signs of peripheral neuropathy. The preferential accumulation of the truncated PrP C1 fragment was closely correlated with these myopathic changes. In this study we use gene expression profiling to explore the temporal program of molecular changes underlying the PrP-mediated myopathy.</p> <p>Results</p> <p>We used DNA microarrays, and confirmatory real-time PCR and Western blot analysis to demonstrate deregulation of a large number of genes in the course of the progressive myopathy in the skeletal muscles of doxycycline-treated Tg(HQK) mice. These include the down-regulation of genes coding for the myofibrillar proteins and transcription factor MEF2c, and up-regulation of genes for lysosomal proteins that is concomitant with increased lysosomal activity in the skeletal muscles. Significantly, there was prominent up-regulation of p53 and p53-regulated genes involved in cell cycle arrest and promotion of apoptosis that paralleled the initiation and progression of the muscle pathology.</p> <p>Conclusion</p> <p>The data provides the first <it>in vivo </it>evidence that directly links p53 to a wild type PrP-mediated disease. It is evident that several mechanistic features contribute to the myopathy observed in PrP over-expressing mice and that p53-related apoptotic pathways appear to play a major role.</p

Unifying Community Detection Across Scales from Genomes to Landscapes

Biodiversity science encompasses multiple disciplines and biological scales from molecules to landscapes. Nevertheless, biodiversity data are often analyzed separately with discipline-specific methodologies, constraining resulting inferences to a single scale. To overcome this, we present a topic modeling framework to analyze community composition in cross-disciplinary datasets, including those generated from metagenomics, metabolomics, field ecology and remote sensing. Using topic models, we demonstrate how community detection in different datasets can inform the conservation of interacting plants and herbivores. We show how topic models can identify members of molecular, organismal and landscape-level communities that relate to wildlife health, from gut microbes to forage quality. We conclude with a future vision for how topic modeling can be used to design cross-scale studies that promote a holistic approach to detect, monitor and manage biodiversity

Umsetzung der Energiestrategie 2050: Herausforderungen und Chancen für Staat und Wirtschaft

Sammelband der Reihe "Energy Governance Working Paper" Nr. 1 bis 7Die Energiestrategie 2050 des Bundes definiert anspruchsvolle Ziele. Für deren Erreichung hat der Bundesrat daher unter anderem den Aktionsplan Energieforschung ins Leben gerufen. Dazu wurden acht sogenannte SCCERs, Swiss Competence Center for Energy Research, initiiert, in denen hochschulübergreifend angewandte Energie-Forschung betrieben wird. Die Zürcher Hochschule für Angewandte Wissenschaften (ZHAW) ist an vier dieser acht SCCERs aktiv beteiligt. Die ZHAW hat diese Aufgabe zum Anlass genommen, Energieforschung zum strategischen Schwerpunkt der gesamten Fachhochschule zu erklären und in allen Departementen Kompetenzaufbauprojekte zu starten. Der vorliegende Sammelband präsentiert die ersten Ergebnisse dieser Kompetenzaufbauprojekte an der School of Management and Law, wobei zwei dieser Projekte in Zusammenarbeit mit Forschern aus den Departementen Angewandte Linguistik und School of Engineering erfolgten. Dabei wurden die Herausforderungen und Chancen, die sich für Staat und Wirtschaft aus der Umsetzung der Energiestrategie 2050 ableiten, auf verschiedenen Ebenen betrachtet: die Schweiz im internationalen Vergleich, Besonderheiten der Führung von EVUs, rechtliche und ökonomische Rahmenbedingungen und die Gestaltung der Energie-Zukunft in Schweizer Städten

Hypertensive Disorders of Pregnancy and DNA Methylation in Newborns Findings From the Pregnancy and Childhood Epigenetics Consortium

Hypertensive disorders of pregnancy (HDP) are associated with low birth weight, shorter gestational age, and increased risk of maternal and offspring cardiovascular diseases later in life. The mechanisms involved are poorly understood, but epigenetic regulation of gene expression may play a part. We performed meta-analyses in the Pregnancy and Childhood Epigenetics Consortium to test the association between either maternal HDP (10 cohorts; n=5242 [cases=476]) or preeclampsia (3 cohorts; n=2219 [cases=135]) and epigenome-wide DNA methylation in cord blood using the Illumina HumanMethylation450 BeadChip. In models adjusted for confounders, and with Bonferroni correction, HDP and preeclampsia were associated with DNA methylation at 43 and 26 CpG sites, respectively. HDP was associated with higher methylation at 27 (63%) of the 43 sites, and across all 43 sites, the mean absolute difference in methylation was between 0.6% and 2.6%. Epigenome-wide associations of HDP with offspring DNA methylation were modestly consistent with the equivalent epigenome-wide associations of preeclampsia with offspring DNA methylation (R-2=0.26). In longitudinal analyses conducted in 1 study (n=108 HDP cases; 550 controls), there were similar changes in DNA methylation in offspring of those with and without HDP up to adolescence. Pathway analysis suggested that genes located at/near HDP-associated sites may be involved in developmental, embryogenesis, or neurological pathways. HDP is associated with offspring DNA methylation with potential relevance to development.Peer reviewe

A miRNA Signature of Prion Induced Neurodegeneration

MicroRNAs (miRNAs) are small, non-coding RNA molecules which are emerging as key regulators of numerous cellular processes. Compelling evidence links miRNAs to the control of neuronal development and differentiation, however, little is known about their role in neurodegeneration. We used microarrays and RT-PCR to profile miRNA expression changes in the brains of mice infected with mouse-adapted scrapie. We determined 15 miRNAs were de-regulated during the disease processes; miR-342-3p, miR-320, let-7b, miR-328, miR-128, miR-139-5p and miR-146a were over 2.5 fold up-regulated and miR-338-3p and miR-337-3p over 2.5 fold down-regulated. Only one of these miRNAs, miR-128, has previously been shown to be de-regulated in neurodegenerative disease. De-regulation of a unique subset of miRNAs suggests a conserved, disease-specific pattern of differentially expressed miRNAs is associated with prion–induced neurodegeneration. Computational analysis predicted numerous potential gene targets of these miRNAs, including 119 genes previously determined to be also de-regulated in mouse scrapie. We used a co-ordinated approach to integrate miRNA and mRNA profiling, bioinformatic predictions and biochemical validation to determine miRNA regulated processes and genes potentially involved in disease progression. In particular, a correlation between miRNA expression and putative gene targets involved in intracellular protein-degradation pathways and signaling pathways related to cell death, synapse function and neurogenesis was identified

An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk

Abstract: It remains elusive whether some of the associations identified in genome-wide association studies of prostate cancer (PrCa) may be due to regulatory effects of genetic variants on CpG sites, which may further influence expression of PrCa target genes. To search for CpG sites associated with PrCa risk, here we establish genetic models to predict methylation (N = 1,595) and conduct association analyses with PrCa risk (79,194 cases and 61,112 controls). We identify 759 CpG sites showing an association, including 15 located at novel loci. Among those 759 CpG sites, methylation of 42 is associated with expression of 28 adjacent genes. Among 22 genes, 18 show an association with PrCa risk. Overall, 25 CpG sites show consistent association directions for the methylation-gene expression-PrCa pathway. We identify DNA methylation biomarkers associated with PrCa, and our findings suggest that specific CpG sites may influence PrCa via regulating expression of candidate PrCa target genes